Bluejay Diagnostics Inc (BJDX)

$2.31 -0.12 (-4.94%)
Market Cap 3.63M
Revenue (ttm) 0.00
Net Income (ttm) -7.72M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 71,900
Avg Vol 3,216,108
Day's Range N/A - N/A
Shares Out 1.49M
Stochastic %K 3%
Beta 0.54
Analysts Strong Buy
Price Target $32.00

Company Profile

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers the Symphony platform, a technology platform comprising the Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and the Symphony Cartridge, which includes reagents and components. It also provides the ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the compa...

Industry: Medical Devices
Sector: Healthcare
Phone: 844 327 7078
Address:
360 Massachusetts Avenue, Suite 203, Acton, United States
DrevanTheStillblade
DrevanTheStillblade Oct. 22 at 8:51 AM
GIPR is built for asymmetry. Low float, clean structure, tangible backing, and technically it’s lining up for a major move. This isn’t about chasing hype it’s about spotting value + structure + technicals before everyone else wakes up. $BJDX $WLDS $CRKN $REVB
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 20 at 2:04 PM
🚀 New Signal ✅ 💊 $BJDX 🗓️ Oct 20, 2025 💵 Entry: $2.64 🎯 Target (Opt.): $3.12 (+18.18%) 👉 FREE TRIAL! Check bio.
0 · Reply
Trendsetta69
Trendsetta69 Oct. 17 at 7:22 PM
$BJDX wanna laugh at this one too?
0 · Reply
GDog877
GDog877 Oct. 17 at 3:59 PM
$BJDX
0 · Reply
GDog877
GDog877 Oct. 16 at 12:57 PM
$BJDX here comes the collapse...
0 · Reply
FinJay
FinJay Oct. 15 at 1:59 PM
🚨 5 Short Squeeze Stocks About to Rip! 🔥 Massive Naked Shorting Exposed 👀 Big moves could be coming soon — don’t miss this breakdown ⬇️ $CRML $BJDX $ELBM $PYXS $DPRO 📺 https://youtu.be/1cmFwhOhgt4
0 · Reply
GDog877
GDog877 Oct. 15 at 1:52 PM
$BJDX
0 · Reply
dominicksolis22
dominicksolis22 Oct. 14 at 5:29 PM
$BJDX Risk is always there but catalysts are scheduled structure entries around dates and respect price levels manage size like a pro and let the science talk 🧠
0 · Reply
GDog877
GDog877 Oct. 14 at 5:14 PM
$BJDX how is this smelly, rancid pos trying to climb again?. lol. Just lie down and stay down there...
1 · Reply
Tell2
Tell2 Oct. 14 at 3:29 PM
$BJDX 😆
0 · Reply
Latest News on BJDX
Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Oct 10, 2025, 5:16 PM EDT - 14 days ago

Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Oct 9, 2025, 3:15 PM EDT - 16 days ago

Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform

Oct 9, 2025, 6:30 AM EDT - 16 days ago

Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform

Bluejay Diagnostics Provides Second Quarter Business and Corporate Update

Aug 7, 2025, 6:30 PM EDT - 2 months ago

Bluejay Diagnostics Provides Second Quarter Business and Corporate Update

Bluejay Diagnostics Provides Mid-Year Business and Corporate Update

Jun 3, 2025, 4:05 PM EDT - 5 months ago

Bluejay Diagnostics Provides Mid-Year Business and Corporate Update

Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Apr 15, 2025, 7:00 AM EDT - 6 months ago

Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds

Apr 7, 2025, 5:21 PM EDT - 7 months ago

Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds

Bluejay Diagnostics Announces Reverse Stock Split

Nov 13, 2024, 5:10 PM EST - 1 year ago

Bluejay Diagnostics Announces Reverse Stock Split

Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering

Jun 28, 2024, 11:32 AM EDT - 1 year ago

Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering

SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients

Jun 26, 2024, 8:00 AM EDT - 1 year ago

SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients

Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering

Jan 2, 2024, 5:58 PM EST - 1 year ago

Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering

Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering

Dec 28, 2023, 8:00 AM EST - 1 year ago

Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering

Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)

Dec 27, 2023, 9:00 AM EST - 1 year ago

Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)

Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Nov 9, 2023, 4:05 PM EST - 2 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Aug 25, 2023, 8:00 AM EDT - 2 years ago

Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results

Aug 16, 2023, 7:00 AM EDT - 2 years ago

Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results

Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy

May 19, 2023, 7:00 AM EDT - 2 years ago

Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy

Bluejay Diagnostics Reports First Quarter 2023 Financial Results

May 10, 2023, 7:30 AM EDT - 2 years ago

Bluejay Diagnostics Reports First Quarter 2023 Financial Results

Bluejay Diagnostics Reports 2022 Financial Results

Mar 20, 2023, 4:15 PM EDT - 2 years ago

Bluejay Diagnostics Reports 2022 Financial Results

Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America

Feb 16, 2023, 8:00 AM EST - 2 years ago

Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America

Bluejay Diagnostics, Inc. Reports Third Quarter 2022 Financial Results

Nov 9, 2022, 8:00 AM EST - 3 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2022 Financial Results

Bluejay Diagnostics (NASDAQ:BJDX), BioSig Technologies (NASDAQ:BSGM) – Sharps Technology And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

Sep 8, 2022, 9:33 AM EDT - 3 years ago

Bluejay Diagnostics (NASDAQ:BJDX), BioSig Technologies (NASDAQ:BSGM) – Sharps Technology And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

STSS

Bluejay Diagnostics, Inc. to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Aug 30, 2022, 4:05 PM EDT - 3 years ago

Bluejay Diagnostics, Inc. to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Bluejay Diagnostics, Inc. to Host Key Opinion Leader Event on IL-6 Testing in Critical Care Settings: The Emerging Use of Biomarkers in Contemporary Management of COVID-19/Respiratory Failure

Aug 16, 2022, 7:30 AM EDT - 3 years ago

Bluejay Diagnostics, Inc. to Host Key Opinion Leader Event on IL-6 Testing in Critical Care Settings: The Emerging Use of Biomarkers in Contemporary Management of COVID-19/Respiratory Failure

Positive Clinical Results for Bluejay's Symphony IL-6 Test Presented at AACC 2022

Jul 27, 2022, 7:30 AM EDT - 3 years ago

Positive Clinical Results for Bluejay's Symphony IL-6 Test Presented at AACC 2022

Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results

Jul 26, 2022, 4:30 PM EDT - 3 years ago

Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results

Bluejay Completes Planned Clinical Studies for Symphony IL-6 Test

Jul 6, 2022, 7:30 AM EDT - 3 years ago

Bluejay Completes Planned Clinical Studies for Symphony IL-6 Test

Why Bluejay Diagnostics Shares Are Surging Higher Today

Jun 9, 2022, 10:19 AM EDT - 3 years ago

Why Bluejay Diagnostics Shares Are Surging Higher Today

Bluejay Diagnostics, Inc. Reports First Quarter 2022 Financial Results

Apr 20, 2022, 4:10 PM EDT - 3 years ago

Bluejay Diagnostics, Inc. Reports First Quarter 2022 Financial Results

Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance

Mar 28, 2022, 7:00 AM EDT - 3 years ago

Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance

Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer

Mar 24, 2022, 7:00 AM EDT - 3 years ago

Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer

Bluejay Diagnostics, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Mar 10, 2022, 7:00 AM EST - 3 years ago

Bluejay Diagnostics, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Bluejay Diagnostics, Inc. Announces its Pre-Submission Filing Package for the Symphony IL-6 Test is with the FDA

Jan 31, 2022, 7:00 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Announces its Pre-Submission Filing Package for the Symphony IL-6 Test is with the FDA

Bluejay Diagnostics, Inc. Completes 90 Subjects in Multicenter Clinical Study Addressing Rapid IL-6 Test for COVID-19 Patients in Critical Care

Jan 13, 2022, 11:29 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Completes 90 Subjects in Multicenter Clinical Study Addressing Rapid IL-6 Test for COVID-19 Patients in Critical Care

Bluejay Diagnostics, Inc. Appoints Mark Feinberg, M.D. as Chief Medical Advisor

Jan 5, 2022, 8:15 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Appoints Mark Feinberg, M.D. as Chief Medical Advisor

Bluejay Diagnostics, Inc. Reports Third Quarter 2021 Financial Results

Dec 16, 2021, 9:11 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2021 Financial Results

Bluejay Diagnostics, Inc. Announces Pricing of Upsized $21.6 Million Initial Public Offering

Nov 10, 2021, 8:15 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Announces Pricing of Upsized $21.6 Million Initial Public Offering

DrevanTheStillblade
DrevanTheStillblade Oct. 22 at 8:51 AM
GIPR is built for asymmetry. Low float, clean structure, tangible backing, and technically it’s lining up for a major move. This isn’t about chasing hype it’s about spotting value + structure + technicals before everyone else wakes up. $BJDX $WLDS $CRKN $REVB
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 20 at 2:04 PM
🚀 New Signal ✅ 💊 $BJDX 🗓️ Oct 20, 2025 💵 Entry: $2.64 🎯 Target (Opt.): $3.12 (+18.18%) 👉 FREE TRIAL! Check bio.
0 · Reply
Trendsetta69
Trendsetta69 Oct. 17 at 7:22 PM
$BJDX wanna laugh at this one too?
0 · Reply
GDog877
GDog877 Oct. 17 at 3:59 PM
$BJDX
0 · Reply
GDog877
GDog877 Oct. 16 at 12:57 PM
$BJDX here comes the collapse...
0 · Reply
FinJay
FinJay Oct. 15 at 1:59 PM
🚨 5 Short Squeeze Stocks About to Rip! 🔥 Massive Naked Shorting Exposed 👀 Big moves could be coming soon — don’t miss this breakdown ⬇️ $CRML $BJDX $ELBM $PYXS $DPRO 📺 https://youtu.be/1cmFwhOhgt4
0 · Reply
GDog877
GDog877 Oct. 15 at 1:52 PM
$BJDX
0 · Reply
dominicksolis22
dominicksolis22 Oct. 14 at 5:29 PM
$BJDX Risk is always there but catalysts are scheduled structure entries around dates and respect price levels manage size like a pro and let the science talk 🧠
0 · Reply
GDog877
GDog877 Oct. 14 at 5:14 PM
$BJDX how is this smelly, rancid pos trying to climb again?. lol. Just lie down and stay down there...
1 · Reply
Tell2
Tell2 Oct. 14 at 3:29 PM
$BJDX 😆
0 · Reply
exclusiveoptions
exclusiveoptions Oct. 14 at 3:14 PM
$BJDX simple to hold. The inflow is there
0 · Reply
HabibiMeaux
HabibiMeaux Oct. 14 at 3:10 PM
$BJDX I wonder if this is gain is from shorts closing their shorts from last week
0 · Reply
Trendsetta69
Trendsetta69 Oct. 14 at 3:08 PM
$BJDX Fake pump 🥱 never holds gains. Always just a swing trade, never long here.
0 · Reply
BullishBee
BullishBee Oct. 14 at 3:01 PM
Profits booked, now for the free ride! 💰 Target 1 smashed on $BJDX. • Entry: $3.42 • Target 1 Hit: $3.68 (+7.5% GAIN) ✅ • Status: RISK-FREE TRADE The bot flagged this mid-morning mover, and we've already hit our first profit target to lock in gains. With the stop moved to our entry, the rest of this trade is pure potential! This isn't just a scanner; it's a complete trading system designed for disciplined entries and intelligent exits. We're showing you the results live before we launch. Our followers will get the launch announcement first. Follow us to be in the know! 💪🐝
0 · Reply
nerowinger
nerowinger Oct. 14 at 2:32 PM
$BJDX LOL
0 · Reply
Stock_Catcher
Stock_Catcher Oct. 14 at 2:24 PM
$BJDX mentioned earlier 24% new high just now
0 · Reply
DaBullRunner
DaBullRunner Oct. 14 at 2:17 PM
$LAES thee it goes… told you about this one from the low $1’s👇🏆✅ COCH adding here before they see what I see 🚢📦📦📦📦📦🚨 $HOND $TVRD $BJDX $UGRO let’s get it
0 · Reply
nerowinger
nerowinger Oct. 14 at 1:57 PM
$BJDX need volume here than we can see 10$ +
0 · Reply
exclusiveoptions
exclusiveoptions Oct. 14 at 1:53 PM
$BJDX
0 · Reply
JediMasterTrader
JediMasterTrader Oct. 14 at 1:51 PM
$BJDX about to explode to next leg up!
0 · Reply
HabibiMeaux
HabibiMeaux Oct. 14 at 1:48 PM
$BJDX I don’t understand the market but I’ll take some nice green candles
0 · Reply
_www_larval_com_
_www_larval_com_ Oct. 14 at 1:47 PM
$BJDX has jumped 12% higher to 19% (~40Kv) a moment ago, follow for more volatility.
0 · Reply